Maastricht University Medical Center | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2026-10-05		NCT06982521
BAROSTIM THERAPY™ In Resistant Hypertension	cardiovascular disorder, hypertensive disorder, vascular disorder	Recruiting	Not stated	2026-09-11		NCT02880631
The "Global Paradise System" Registry	cardiovascular disorder, hypertensive disorder, vascular disorder	Recruiting	Not stated	2026-06-04		NCT05027685
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence	Hernia, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications	Active, not recruiting	Not applicable	2026-05-06		NCT05424484
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation	Death, Death, Sudden, Death, Sudden, Cardiac, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiac arrest, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Recruiting	Not applicable	2026-04-01		NCT05665608
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study	Corneal Endothelial Cell Loss, Eye Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, corneal disorder, eye disorder	Recruiting	Not stated	2025-10-02		NCT05847387